Stéphane De Lombaert

1.6k total citations
49 papers, 1.2k citations indexed

About

Stéphane De Lombaert is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Stéphane De Lombaert has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Physiology and 14 papers in Organic Chemistry. Recurrent topics in Stéphane De Lombaert's work include Nitric Oxide and Endothelin Effects (13 papers), Peptidase Inhibition and Analysis (9 papers) and Neuropeptides and Animal Physiology (7 papers). Stéphane De Lombaert is often cited by papers focused on Nitric Oxide and Endothelin Effects (13 papers), Peptidase Inhibition and Analysis (9 papers) and Neuropeptides and Animal Physiology (7 papers). Stéphane De Lombaert collaborates with scholars based in United States, Switzerland and France. Stéphane De Lombaert's co-authors include Arco Y. Jeng, Angelo J. Trapani, Louis Blanchard, Léon Ghosez, Jenny Tan, Alison Kukulka, Neil A. Farrow, Yumi Sakane, Anne B. Eldrup and Carol Berry and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Stéphane De Lombaert

49 papers receiving 1.1k citations

Peers

Countries citing papers authored by Stéphane De Lombaert

Since Specialization

Citations

This map shows the geographic impact of Stéphane De Lombaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane De Lombaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane De Lombaert more than expected).

Fields of papers citing papers by Stéphane De Lombaert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane De Lombaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane De Lombaert. The network helps show where Stéphane De Lombaert may publish in the future.

Co-authorship network of co-authors of Stéphane De Lombaert

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane De Lombaert. A scholar is included among the top collaborators of Stéphane De Lombaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane De Lombaert. Stéphane De Lombaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors	Bioorganic & Medicinal Chemistry Letters	Daniel R. Goldberg, Stéphane De Lombaert et al.	29
2	Discovery of acyl guanidine tryptophan hydroxylase-1 inhibitors	Bioorganic & Medicinal Chemistry Letters	Daniel R. Goldberg, Stéphane De Lombaert et al.	11
3	Discovery of Potent, Selective Chymase Inhibitors via Fragment Linking Strategies	Journal of Medicinal Chemistry	Steven J. Taylor, Anil K. Padyana et al.	23
4	Benzimidazolone as potent chymase inhibitor: Modulation of reactive metabolite formation in the hydrophobic (P1) region	Bioorganic & Medicinal Chemistry Letters	Jin‐Man Kim, Ming‐Hong Hao et al.	16
5	Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase	Bioorganic & Medicinal Chemistry Letters	Steven J. Taylor, Anne B. Eldrup et al.	16
6	Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase	Bioorganic & Medicinal Chemistry Letters	Anne B. Eldrup, Neil A. Farrow et al.	32
7	Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution	Bioorganic & Medicinal Chemistry Letters	Charles A. Blum, Xiaozhang Zheng et al.	13
8	Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design	Bioorganic & Medicinal Chemistry Letters	Brian N. Cook, Jörg Bentzien et al.	29
9	2-Arylpyrimidines: Novel CRF-1 receptor antagonists	Bioorganic & Medicinal Chemistry Letters	Tae‐young Yoon, Stéphane De Lombaert et al.	8
10	2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists	Bioorganic & Medicinal Chemistry Letters	Kevin J. Hodgetts, Tae‐young Yoon et al.	14
11	3-Aryl pyrazolo[4,3-d]pyrimidine derivatives	Bioorganic & Medicinal Chemistry Letters	Jun Yuan, Michael Gulianello et al.	30
12	Cgs 34043	Life Sciences	Angelo J. Trapani, Stéphane De Lombaert et al.	10
13	Design and Synthesis of a Potent and Selective Endothelin-Converting Enzyme Inhibitor, CGS 35066	Journal of Cardiovascular Pharmacology	Arco Y. Jeng, Stéphane De Lombaert et al.	19
14	Pharmacological Properties of CGS 35066, a Potent and Selective Endothelin-Converting Enzyme Inhibitor, in Conscious Rats	Journal of Cardiovascular Pharmacology	Angelo J. Trapani, Michael E. Beil et al.	17
15	Differential Inhibition of Wild-Type Endothelin-Converting Enzyme-1 and Its Mutants	Journal of Cardiovascular Pharmacology	Paula Savage, Stéphane De Lombaert et al.	2
16	Antihypertensive and Natriuretic Effects of CGS 30440, a Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11	Journal of Pharmacology and Experimental Therapeutics	Angelo J. Trapani, Stéphane De Lombaert et al.	18
17	Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11	Bioorganic & Medicinal Chemistry Letters	Stéphane De Lombaert, Louis Blanchard et al.	26
18	Design and Pharmacology of Dual Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitors	Current Pharmaceutical Design	Stéphane De Lombaert, Cynthia A. Fink et al.	9
19	Inhibition of Big ET-1-Induced Pressor Response by an Orally Active Dual Inhibitor of Endothelin-Converting Enzyme and Neutral Endopeptidase 24.11	Journal of Cardiovascular Pharmacology	Angelo J. Trapani, Stéphane De Lombaert et al.	20
20	N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) Inhibitors	Journal of Medicinal Chemistry	Stéphane De Lombaert, Mark D. Erion et al.	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact